AML Or Acute Myeloid Leukemia Patients With IDH2 Mutations Get New FDA Approved Drug, Idhifa, For Treatment Medicine & Technology Aug 03, 2017 The FDA has recently approved a new drug Idhifa to treat the AML patients with the IDH2 mutations.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts